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EPIDEMIOLOGY
Is diabetic nephropathy an inherited complication?
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Steno Diabetes Centre, Gentofte, Denmark
Is diabetic nephropathy an inherited complication? For yet unidenti-
fied reasons less than 50% of patients with insulin-dependent mellitus
develop diabetic nephropathy. Genetic factors have been suggested as
risk markers for development of nephropathy in diabetes. To further
evaluate this hypothesis we studied the prevalence of nephropathy in
diabetic siblings of diabetic patients with and without nephropathy.
From a representative sample of 619 patients with insulin-dependent
diabetes, we identified 20 patients with and 29 patients without
nephropathy having diabetic siblings. Diabetic nephropathy (defined as
urinary albumin excretion > 300 mg/24 hr) was found in 7 out of 21
siblings to patients with nephropathy and 3 out of 30 siblings to
normoalbuminuric patients (P < 0.04). No significant differences be-
tween the two groups of siblings with respect to age, diabetes duration,
sex distribution, blood pressure or glycosylated hemoglobin A Ic-levels
were found. A significant correlation within sib-pair of glycosylated
hemoglobin Ale was found (r = 0.47; P < 0.001). We conclude that
familial clustering of diabetic nephropathy does occur. This clustering
may either be due to genetic inheritance or to sib-similarities due to
shared environment, as indicated by the correlation of glycosylated
hemoglobin Aic within sib-pairs.
Diabetic nephropathy is the strongest predictor of premature
death and cardiovascular diseases yet identified in insulin-
dependent diabetic patients [1, 2]. Diabetic nephropathy typi-
cally develops after 15 to 25 years of diabetes duration but 50 to
70% of all patients do not develop this complication despite the
long duration of diabetes [1—3]. This heterogeneity within the
diabetic population appears to be unexplainable by metabolic
regulation alone [2]. Therefore, other factors—including genet-
ic—have been suggested as determinants of the risk of devel-
oping diabetic nephropathy. In a study of familial clustering of
nephropathy, Seaquist et al [4] found that the prevalence of
nephropathy was 83% in diabetic siblings to patients who had
already developed diabetic nephropathy, while the prevalence
was only 17% in diabetic siblings to normoalbuminuric diabetic
patients. They concluded that their observation was "consis-
tent with the hypothesis that heredity helps to determine
susceptibility to diabetic nephropathy."
The aim of the present study was to investigate the concor-
dance rates for the presence or absence of renal involvement in
siblings with insulin-dependent diabetes mellitus, as genetically
determined susceptibility to diabetic nephropathy would lead to
familial clustering of this late diabetic complication.
Methods
From the files in two specialized diabetes care units in
Copenhagen (Steno Memorial Hospital and HvidØre Hospital)
treating more than 70% of all insulin-dependent diabetic pa-
tients in the Copenhagen area, we identified all patients attend-
ing the hospitals in the period of September 1, 1988 to May 31,
1989, fulfilling the following criteria: diabetes onset before the
age of 40 years, unbroken record of insulin treatment, diabetes
duration  10 years and presence of clinical diabetic nephrop-
athy defined as 24-hour urinary protein excretion >0.5 g (or
urinary albumin excretion >300 mg) in at least three consecu-
tive, sterile 24-hour urine samples, and no clinical or laboratory
evidence of kidney or renal tract disease other than diabetic
glomerulosclerosis.
Screening for proteinuria was performed in all patients at
each out-patient clinic visit (3 to 4 month intervals). Screening
was performed by Album test, and if positive this was followed
by a quantitative measurement of albumin [5].
An equal number of patients fulfilling the three first criteria
but with urinary albumin excretion in the normal range (< 20
mg/24 hr in at least 2 out of 3 consecutive samples) were
randomly chosen from our hospital files. We identified 292
patients with nephropathy (158 from Steno Memorial Hospital,
134 from HvidØre Hospital) and 327 normo-albuminuric pa-
tients (178 and 151 from the 2 hospitals, respectively). All
patients were asked if they had siblings with diabetes (dead or
alive) and in that case to give a written consent to contact their
diabetic siblings. If consent was given, the sibling was invited to
participate in the study, and if the sibling had died, clinical data
including available information concerning late diabetic compli-
cations were obtained from the hospital where the patient had
died. Figure 1 shows the flow chart for identification of siblings
concordant for insulin-dependent diabetes.
We identified 24 probands with clinical nephropathy and 34
normoalbuminuric probands who had at least one sibling with
insulin-dependent diabetes mellitus. Sib-pairs where the sibling
had a diabetes duration below five years were excluded, as the
aim of the study was to investigate the concordance rate for
diabetic nephropathy. Thus, 21 probands with nephropathy
(group 1) and 31 normoalbuminuric probands (group 2) fulfilled
all criteria for inclusion. From group 1, 20 probands partici-
pated (95%) with 18 living and 3 dead siblings and from group 2,
29 (94%) probands participated with 27 living and 3 dead
siblings.
In all 49 probands and the 45 siblings still alive were mea-
sured: height, weight, arterial blood pressure twice after 10© 1992 by the International Society of Nephrology
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mellitus and significantly higher glycosylated hemoglobin Aic
values than normoalbuminuric probands (group 2).
Siblings
The 20 probands in group 1 had 21 siblings with insulin-
dependent diabetes mellitus and the 29 probands in group 2 had
30 siblings with insulin-dependent diabetes mellitus. Table I
gives the clinical data of the two groups of siblings, and no
significant differences were found between the two groups. As
shown in Table 2 the groups of siblings to probands with clinical
nephropathy had a significantly higher prevalence of overt
nephropathy than siblings to normoalbuminuric probands (33%
vs. 10%, P < 0.04). High microalbuminuria or clinical nephrop-
athy (that is, urinary albumin excretion >100 mg/24 hr) was
found in 43% of siblings to probands with nephropathy and 13%
of siblings of normoalbuminuric probands. Thus, the odds-ratio
for high microalbuminuria or clinical nephropathy was 4.9 (95%
confidence limits 1.3 to 19.1) in siblings to patients with
nephropathy. In siblings to patients with proteinuria 48% were
normoalbuminuric compared to 73% in siblings to normoalbu-
minuric probands (P = 0.06, chi-square 3.49). Forty-eight
percent of the siblings of probands with nephropathy received
antihypertensive medication versus 17% of siblings of normoal-
buminuric probands (P < 0.02). This difference was due to
higher frequency of clinical proteinuria in the first group.
Within the individual sib pair (independent of nephropathy
status of the proband) a significant positive correlation was
found between the glycosylated hemoglobin A ic-value of
proband and sibling (r = 0.47, P < 0.001; Fig. 2).
Discussion
Our study confirmed the observation of familial clustering of
diabetic nephropathy previously reported by Seaquist et al [4].
We found that the odds ratio for clinical nephropathy or high
microalbuminuria was 4.9 in siblings to patients with nephrop-
athy compared to siblings to normoalbuminuric patients. This
odds ratio was lower than (but not significantly different from)
the odds ratio of 24 found by Seaquist et al. We defined high
microalbuminuria as a urinary albumin excretion of 101 to 300
mg124 hr in at least two out of three 24-hour urine samples. This
level of albuminuria has been shown to be a strong predictor of
later progression to clinical nephropathy, while patients in the
range of 30 to 100 mg/24 hr have a 50% chance of remaining
stable or even return to normoalbuminuria over several years
[6, 71. This latter phenomenon may—together with the limited
sample size—explain why the study just failed to show conven-
tional significance (P = 0.06) when using 30 mg/24 hr as
discriminatory level.
In the present study 619 patients were questioned about
family history of diabetes, and we had a reply rate of 94%.
Among the 52 probands identified fulfilling the inclusion criteria
94% of their siblings participated in the study. Thus, the degree
of ascertainment was 88%. We have previously shown that
patients treated at the Steno Memorial Hospital are repre-
sentative of all Danish insulin-dependent diabetic patients with
respect to age at onset, sex distribution and factors affecting
mortality [2]. As referral of patients to HvidØre Hospital has
followed the same lines as to the Steno Memorial Hospital, it is
unlikely that these patients are less representative of all Danish
insulin-dependent diabetic patients. Thus, the basic population
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Probands with IDDM-siblings
Siblings with diabetes 3duration <5years L_J
Probands eligible for study 31
Participation rejected 2
Families included 29
Siblings included 30
Siblings dead 3
Siblings studied 27
Fig. 1. Flow chart for identification of probands and siblings
minutes at rest in supine position (using an automatic device,
Takeda Medical UA-751, Tokyo, Japan), glycosylated hemo-
globin AIc [5], urinary albumin excretion in three sterile
24-hour urine samples [6], and serum creatinine concentration.
Urinary albumin excretion was classified as normal < 30 mg/24
hr, low microalbuminuria 30 to 100 mg/24 hr, high microalbu-
minuria 101 to 300 mg124 hr, or clinical nephropathy >300
mg/24 hr. Ophthalmoscopy was performed on dilated pupils on
both eyes, classified as normal, background and proliferative or
laser treated according to the worst affected eye. We recorded
gender, age, age at diagnosis of diabetes, diabetes duration,
insulin dose and medication other than insulin. Six siblings had
died, and available data were collected as described previously.
Statistical analysis
Differences between groups were tested by unpaired Stu-
dent's t-test if normally distributed, otherwise with Mann-
Whitney test. Distribution of hypertension, retinopathy and
overt and/or incipient nephropathy was tested using a Chi-
square test. Within sib-pair correlation of glycosylated hemo-
globin Alc was tested using linear regression analysis.
All results are given as mean (± 1 SD) if normally distributed,
otherwise as median ranges.
Results
Probands
Twenty probands with nephropathy and 29 normoalbumin-
uric probands were included. Table 1 shows the clinical data of
the two groups. Probands with nephropathy (group 1) had
significantly lower age at onset of insulin-dependent diabetes
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Table 1. Clinical data on probands and siblings
Probands with
Proteinuria
(Group I)
UAER
< 20 mg/24 hr
(Group 2)
Siblings
Group 1 Group 2(N 20) (N = 29) P (N = 21) (N = 30) P
Age years 39 10 41 II — 38 Ii 38 10 —
Age at onset years 12 7 17 II 0.055 17 11 17 10 —
Diabetes duration years 27 10 23 6 — 22 10 20 12 —
Male/female 11/9 17/12 — 10/Il 14/16 —
Insulin dose lu/kg 0.55 0.15 0.58 0.15 0.61 0.15 0.68 0.26 —
HbAlc % 9.4 1.5 8.4 1.2 <0.02 9.0 1.5 9.0 2.4 —
Systolic BP mm Hg 146 23 136 20 — 133 20 128 21 —
Diastolic BP mm Hg 84 9 79 8 — 82 12 76 12 —
Antihypertensive medication % 80 (56—94) 3 (0—18) <0.0001 48 (26—70) 17 (6—36) <0.02
Creatinine p.mol/liter 133 21 75± 9 <0.0001 79 16 78 17 —
Data are given as mean1 SD. Antihypertensive medication is recorded as actual value (95% conf. limits); — is not significant (P > 0.1).
Siblings of
Group 1 Group 2
(N='21) (N=30) P
Urinary albumin excretion rate
Median value mg/24 hr 79 (8—558) 14 (3—400) <0.03
No. with:
Normal (< 30 mg/24 hr) 10 22
Low microalb. (30—100 mg/ 2 4 c
24 hr)
High microalb. (101—300 mg/ 2 1 b, c
24 hr)
Nephropathy 7 3 a, b, c
Retinopathy
None % 40 (1964)d 34 (18_54)d
Simplex %
Proliferative % or laser treated
30 (12—54)"
30 (1254)d
41 (23—61)"
24 (10-44)d
NS
was representative, and the high degree of ascertainment ex-
cludes the possibility of major selection biases.
Familial clustering of diabetic nephropathy does, however,
not necessarily imply classical genetical inheritance. Familial
clustering may represent genetical inheritance as well as "spu-
rious" inheritance (that is, sib-similarities due to shared envi-
ronment).
Several mechanisms for genetic inheritance have been sug-
gested. Familial predisposition to essential hypertension as a
risk factor for development of diabetic nephropathy was first
suggested by Viberti, Keen and Wiseman [8]. They compared
the blood pressure of parents of 17 patients with and 17 patients
without diabetic nephropathy, and found significantly higher
blood pressure levels in the parents of patients with nephrop-
athy. Their observation was later supported by Krolewski et al
[9]. They found a higher prevalence of hypertension diagnosed
before the age of 60 years in parents of patients with diabetic
nephropathy than in parents of normoalbuminuric patients.
Their conclusion was, however, not based on blood pressure
measurements but on questionnaires to the parents or their
S
. S• 1..•S.
S
nearest relative. In a recent study by Walker, Tariq and Viberti
[101 including 80 parents of insulin-dependent diabetic patients
with and without proteinuria, no difference in blood pressure
was found in the two groups of parents. In a family study
including 80 parents of insulin-dependent diabetic patients with
overt nephropathy and 78 parents of patients with normoalbu-
minuria, we were also unable to find any difference in the blood
pressure between the two groups of parents [12]. Thus conflict-
ing evidence has been given regarding the importance of familial
predisposition to essential hypertension as a risk factor for
development of diabetic nephropathy.
Krolewski et al [9] and Mangili et al [121 have suggested that
increased red cell sodium-lithium countertransport, a possible
genetic marker for essential hypertension, should also be a
genetic marker for diabetic nephropathy. Both groups have
found higher sodium-lithium counter-transport activity in pa-
tients with diabetic nephropathy than in normoalbuminuric
Table 2. Retinal status and urinary albumin excretion in siblings of
patients with diabetic nephropathy (Group I) and normoalbuminuria
(Group 2)
. .
CI)
CI)
CI
C-)
I
17.0
1
15.0 -
13.0 -
11.0 -
9.0
7.0
5.0
.1. .•
•.S
Group 1 vs. group 2: (a) nephropathy P = 0.035; (b) incipient or overt
nephropathy (>100 mg/24 hr), P = 0.017; (c) normoalbuminuria vs.
others, P = 0.06; "(95% confidence interval).
U— I I I I
6.0 8.0 10.0 12.0 14.0
HbAlc, % in pro bands
Fig. 2. Glycosylated hemoglobin Aic values inprobands and siblings.
= 0.47, P = 0.001.
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patients. This hypothesis was supported by a British family
study 1101, where higher sodium-lithium countertransport was
found in parents of patients with proteinuria than in parents of
normoalburninuric patients. In our own family study [111,
including larger number of parents we did not, however, find
any difference in sodium-lithium countertransport in the two
groups of parents. We did confirm the increased activity in
patients with nephropathy compared with normoalbuminuric
patients, but both diabetic groups had significantly higher
activity than non-diabetic controls, Thus, this observation
indicate that increased activity may be a consequence of
diabetes per se and not a risk marker for development of
nephropathy.
Thus, genetic factors may play a role as a risk factor for
diabetic nephropathy but the final proof is still awaited. Familial
clustering of diabetic nephropathy does, however, not prove
that genetic factors are involved. Sharing of environment during
childhood and adolescence probably induces sib-similarities. If
these sib-similarities included factors of importance in the
etiology of diabetic nephropathy they would mimic genetic
inheritance and lead to familial clustering. It is likely that, for
example, dietary habits and smoking habits are heavily influ-
enced by the habits of the household. As high protein intake
[13] and cigarette smoking [14, 15] both have been found to be
associated with nephropathy or increased mortality, these
factors may be involved in familial clustering of diabetic
nephropathy.
In the present study we found a significant positive correla-
tion between glycosylated hemoglobin Ale values within the
individual sib-pairs. This observation could be due to non-
genetic factors (such as, dietary habits and attitude towards
diabetes and self-care) or potential genetic factors (such as,
insulin resistance). As poor metabolic control has been shown
to increase the risk of developing diabetic nephropathy [2, 16,
17] this observation may at least in part explain the familial
clustering of diabetic nephropathy. We do, however, only have
data on metabolic regulation at the time of the study, while data
on the period from diabetes onset until the time of the study
were unobtainable. Thus, we were unable to study the relative
impact of metabolic control on the risk of developing nephrop-
athy.
In conclusion, we observed a fivefold increase in the proba-
bility of having high microalbuminuria or clinical nephropathy if
the sibling had diabetic nephropathy. The etiology of familial
clustering remains unexplained, but the observed correlation of
metabolic regulation within sib-pairs indicates that non-genetic
sib-similarities may play an important role.
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